Prenetics Global Limited Board of Directors

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.

Mr. Sheng Wu Yeung

Mr. Sheng Wu Yeung

Co-Founder, Chairperson & CEO

Mr. Hoi Chun Lo

Mr. Hoi Chun Lo

Chief Financial Officer

Dr. Chi Hung Tzang Ph.D.

Dr. Chi Hung Tzang Ph.D.

Co-Founder & Chief Scientific Officer

Mr. Joel Neoh

Mr. Joel Neoh

Chief Consumer Officer & CEO for CircleDNA

Dr. Yung Ho Wong DPHIL

Dr. Yung Ho Wong DPHIL

Chief Technology Officer

Mr. Walt Ling

Mr. Walt Ling

Chief Executive Officer of ACT Genomics

Dr. Senthil Sundaram M.D.

Dr. Senthil Sundaram M.D.

Chief Clinical Officer

Ms. Samantha Kwok

Ms. Samantha Kwok

Chief of Staff to Group CEO & Vice President of People & Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.